A patient at API complained that the resident physician was mismanaging her diabetes medication, jeopardizing her health. The Ombudsman cannot second-guess the medical opinion of a licensed professional, however it was clear that API failed to follow its grievance policy, which required the medication issue to be reviewed by the facility CEO, who would provide a written response to the grievance. The grievance was not forwarded to the CEO, and therefore, not answered. In the meantime, the patient was transferred to a treatment provider rendering the medication issue moot. However, API management agreed to provide training to staff to prevent future occurrences. (A2016-1667)